Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Miglustat (NB-DNJ) is an alkylated product of imino sugar deoxynojirimycin.It is an inhibitor of glucosylceramide synthase, primarily to treat Type I Gaucher disease (GD1).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 38.00 | |
5 mg | In stock | $ 89.00 | |
10 mg | In stock | $ 139.00 | |
25 mg | In stock | $ 258.00 | |
50 mg | In stock | $ 428.00 | |
100 mg | In stock | $ 623.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 98.00 |
Description | Miglustat (NB-DNJ) is an alkylated product of imino sugar deoxynojirimycin.It is an inhibitor of glucosylceramide synthase, primarily to treat Type I Gaucher disease (GD1). |
Synonyms | N-Butyldeoxynojirimycin, OGT918, NB-DNJ |
Molecular Weight | 219.28 |
Formula | C10H21NO4 |
CAS No. | 72599-27-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 25 mg/mL (114.01 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Miglustat 72599-27-0 Others oral Inhibitor inhibit OGT 918 ceramide glucosyltransferase N-Butyldeoxynojirimycin OGT918 OGT-918 NB-DNJ type I gaucher disease inhibitor